PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
1-Year Return 3.82%
This Quarter Return
+9.27%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$751M
AUM Growth
+$241M
Cap. Flow
+$159M
Cap. Flow %
21.16%
Top 10 Hldgs %
38.08%
Holding
168
New
36
Increased
30
Reduced
20
Closed
26

Top Buys

1
COO icon
Cooper Companies
COO
$27M
2
PPD
PPD, Inc. Common Stock
PPD
$22.2M
3
OM icon
Outset Medical
OM
$17M
4
VCEL icon
Vericel Corp
VCEL
$16.7M
5
AFIB
Acutus Medical, Inc. Common Stock
AFIB
$15.9M

Top Sells

1
INSP icon
Inspire Medical Systems
INSP
$9.96M
2
LHCG
LHC Group LLC
LHCG
$9.32M
3
LIVN icon
LivaNova
LIVN
$7.29M
4
BSX icon
Boston Scientific
BSX
$6.44M
5
OSUR icon
OraSure Technologies
OSUR
$5.65M

Sector Composition

1 Healthcare 81.75%
2 Industrials 1.96%
3 Consumer Staples 1.16%
4 Energy 0.64%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NVRO
51
DELISTED
NEVRO CORP.
NVRO
$4.44M 0.23%
+31,838
New +$4.44M
BNR
52
Burning Rock Biotech
BNR
$89.4M
$4.43M 0.23%
+17,664
New +$4.43M
TWST icon
53
Twist Bioscience
TWST
$1.55B
$4.37M 0.23%
57,581
-50,600
-47% -$3.84M
OPCH icon
54
Option Care Health
OPCH
$4.72B
$4.35M 0.22%
+325,000
New +$4.35M
APYX icon
55
Apyx Medical
APYX
$74.1M
$4.25M 0.22%
902,847
+77,730
+9% +$366K
CMPS
56
Compass Pathways
CMPS
$493M
$4.03M 0.21%
+115,494
New +$4.03M
AVDL
57
Avadel Pharmaceuticals
AVDL
$1.53B
$4.01M 0.21%
795,200
+232,400
+41% +$1.17M
ITMR
58
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.88M 0.2%
190,074
+12,527
+7% +$256K
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.85M 0.2%
+150,000
New +$3.85M
CUTR
60
DELISTED
Cutera, Inc.
CUTR
$3.48M 0.18%
+183,275
New +$3.48M
STXS icon
61
Stereotaxis
STXS
$264M
$3.23M 0.17%
902,275
– –
KURA icon
62
Kura Oncology
KURA
$713M
$3.13M 0.16%
+102,066
New +$3.13M
KRMD icon
63
KORU Medical Systems
KRMD
$188M
$2.95M 0.15%
408,516
-21,400
-5% -$154K
LYRA icon
64
Lyra Therapeutics
LYRA
$11.3M
$2.54M 0.13%
4,534
+574
+14% +$321K
BCRX icon
65
BioCryst Pharmaceuticals
BCRX
$1.74B
$2.48M 0.13%
721,919
+285,419
+65% +$980K
AVTR icon
66
Avantor
AVTR
$9.07B
$2.36M 0.12%
+105,000
New +$2.36M
FOLD icon
67
Amicus Therapeutics
FOLD
$2.46B
$2.23M 0.12%
158,200
+55,900
+55% +$789K
ARDX icon
68
Ardelyx
ARDX
$1.57B
$2.2M 0.11%
418,908
+22,367
+6% +$117K
CLDX icon
69
Celldex Therapeutics
CLDX
$1.52B
$2.14M 0.11%
144,200
-105,900
-42% -$1.57M
BMY.RT
70
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.99M 0.1%
886,222
+424,600
+92% +$955K
RAPT icon
71
RAPT Therapeutics
RAPT
$214M
$1.61M 0.08%
+6,250
New +$1.61M
CHAQ.U
72
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$1.58M 0.08%
153,960
– –
FPRX
73
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.52M 0.08%
322,452
+311,352
+2,805% +$1.46M
PSTX
74
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.32M 0.07%
+148,949
New +$1.32M
OBIO icon
75
Orchestra BioMed
OBIO
$148M
$1.1M 0.06%
+100,000
New +$1.1M
1 2
3
4 5